In this new Pandemic Response series, StartUp Health's senior writer, Nicole Clark talks with Italy-based Andrea Riposati, CEO of Dante Labs, about how his DNA tests are being used to sequence the whole genome of patients with COVID-19. His aim? To understand what genes play a role in our reaction to the deadly disease.